Drug intelligence / Profile preview

recombinant human chorionic gonadotropin alpha (Joincare)

Development stage: Unknown
Lead developer: Joincare Pharmaceutical
Modality: Recombinant Proteins and Enzymes
Administration: Injection

Overview

Recombinant human chorionic gonadotropin alpha (r-hCG alpha) is a recombinant protein biologic developed by Joincare Pharmaceutical Group Industry for use in assisted reproductive technology (ART). It acts as an agonist at the luteinizing hormone/chorionic gonadotropin (LH/hCG) receptor, mimicking the natural LH surge to induce final follicular maturation and ovulation in women undergoing infertility treatment. Produced via recombinant DNA technology, it offers higher purity and consistency compared to traditional urinary-derived hCG preparations. The drug is administered by injection and is approved in China for the treatment of female infertility.

Other names: recombinant human chorionic gonadotropin alphar-hCG alpha

Targets

FSHR (Follicle-stimulating hormone receptor)LHCGR (Luteinizing hormone/choriogonadotropin receptor)

Beyond the preview

Go deeper on recombinant human chorionic gonadotropin alpha (Joincare).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant human chorionic gonadotropin alpha (Joincare).

Explore the full profile